Dipeptides containing alanine from dry cured ham have been reported to have the ability to inhibit angiotensin-converting enzyme (ACE) and dipeptidyl peptidase IV (DPP IV), making them potential candidates for anti-hypertension and anti-hyperglycemic therapeutic agents, respectively (Gallego et al., 2019;Messerli et al., 2018;Deacon, 2020). Here, ACE is linked to hypertensive disorder.